Intestinal alkaline phosphatase in the colonic mucosa of children with inflammatory bowel disease

Table 1 Clinical characteristics of newly diagnosed patients with Crohn's disease and ulcerative colitis

Patient	Form of IBD	Gender	Age (yr)	Main complaints at presentation	Activity score	Duration (symptoms) (mo)
1	CD	F	15	Perianal fistula	25	1
2	CD	M	4	Hematochezia	20	3
3	CD	M	11	Abdominal pain, diarrhea	45	2
4	CD	F	9	Bloody diarrhoea	25	2
5	CD	F	4	Diarrhoea, anaemia	30	3
6	CD	M	14	Hematochezia	50	6
7	CD	F	1.5	Bloody diarrhoea	35	1.5
8	CD	M	11	Bloody diarrhoea	20	2
9	CD	M	12	Diarrhoea, anaemia	35	3
10	CD	M	10	Weight loss, diarrhea	52.5	1.5
11	UC	F	12	Hematochezia, abdominal pain	20	4
12	UC	M	9	Hematochezia, anaemia	35	1
13	UC	M	17	Hematochezia, abdominal pain	25	7
14	UC	F	12	Hematochezia, weight loss	55	4
15	UC	M	6	Hematochezia	40	2.5

The activity score was calculated by means of pediatric Crohn’s disease activity index and pediatric ulcerative colitis activity index. IBD: Inflammatory bowel disease; CD: Crohn’s disease; UC: Ulcerative colitis; M: Male; F: Female.